Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT04307277
Recruiting
Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Phase 3 · France · 21 sites
Registry update: 16 Oct 2026
NCT04577014
Recruiting
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Phase 1/2 · United States · 1 site
Registry update: 8 Sept 2026
NCT04557449
Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Phase 1/2 · Argentina, China, Czechia, United Kingdom, Japan, Mexico, Slovakia, United States · 41 sites
Registry update: 28 Oct 2026
Conflicting statuses (updated in the registry within the last month)
NCT04370587
Recruiting
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Phase 1/2 · Australia, United States · 9 sites
Registry update: 8 Oct 2025
NCT04625907
Recruiting
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Phase 1/2 · Austria, Australia, Belgium, Switzerland, Czechia, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Ireland, Israel, Italy, Netherlands, Norway, New Zealand, Portugal, Sweden, Slovenia, Slovakia · 226 sites
Registry update: 23 May 2024
2024-513033-21-00
Recruiting
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
Phase 1 · Spain, France, Italy, Netherlands · 4 sites
Registry update: 14 Aug 2026
NCT04986748
Recruiting
Using QPOP to Predict Treatment for Sarcomas and Melanomas
Not applicable · Singapore · 1 site
Registry update: 1 Jul 2025
NCT04390737
Recruiting
Evaluate the Safety and Clinical Activity of HH2853
Phase 1/2 · China, United States · 22 sites
Registry update: 30 Jan 2026
NCT04224064
Recruiting
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
Not applicable · France · 1 site
Registry update: 12 Feb 2025
NCT03965234
Recruiting
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Phase 1/2 · United States · 1 site
Registry update: 21 Aug 2026
NCT04303117
Recruiting
PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
Phase 1/2 · United States · 1 site
Registry update: 16 Oct 2026
NCT04273061
Recruiting
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Phase 2 · Canada · 2 sites
Registry update: 16 Sept 2026
NCT03548428
Recruiting
Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)
Phase 2 · France · 17 sites
Registry update: 19 Feb 2025
Conflicting statuses (not updated in the registry for 20 months)
NCT05167994
Recruiting
Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01）
Phase 2 · China · 1 site
Registry update: 4 Jun 2026
NCT04332874
Recruiting
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
Phase 2 · United States · 7 sites
Registry update: 23 Apr 2026
NCT04094610
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Phase 1/2 · Australia, Canada, Denmark, Spain, France, United Kingdom, Italy, South Korea, Singapore, Taiwan, United States · 57 sites
Registry update: 25 Sept 2026
NCT04055220
Recruiting
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
Phase 3 · France · 17 sites
Registry update: 17 Feb 2026
Conflicting statuses (not updated in the registry for 8 months)
NCT04330456
Recruiting
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy
Not applicable · Russia · 1 site
Registry update: 1 Apr 2020
NCT04188535
Recruiting
Serial MRI Scans During Radiation Therapy
Not applicable · United States · 2 sites
Registry update: 2 Sept 2026
NCT04166006
Recruiting
A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
Phase 2 · Italy · 1 site
Registry update: 19 Sept 2024

Ordered by registry start date. Freshness and sponsorship never change the order.